Player FMアプリでオフラインにしPlayer FMう!
Vertex submits NDA for CF drug, MacroGenics reports ADC prostate cancer trial patient deaths, FTC extends review of Novo-Catalent deal [The good, the bad, the ugly]
Manage episode 418067046 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Vertex submits NDA for CF drug
The bad — MacroGenics reports patient deaths in prostate cancer ADC trial
The ugly — FTC extends review of Novo-Catalent deal
64 つのエピソード
Manage episode 418067046 series 2941835
Join us each week as we do a quick review of three compelling stories from the pharma world — one good, one bad and one ugly. Up this week:
The good — Vertex submits NDA for CF drug
The bad — MacroGenics reports patient deaths in prostate cancer ADC trial
The ugly — FTC extends review of Novo-Catalent deal
64 つのエピソード
Alle episoder
×プレーヤーFMへようこそ!
Player FMは今からすぐに楽しめるために高品質のポッドキャストをウェブでスキャンしています。 これは最高のポッドキャストアプリで、Android、iPhone、そしてWebで動作します。 全ての端末で購読を同期するためにサインアップしてください。